Total Funding
21
43
Total FundingPost-IPO Equity raised
Growth Score
1 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
180786
Destiny Pharma Ltd., a clinical stage pharmaceutical company
- Shaun Claydon: Chief Financial Officer and Company Secretary
- Stephanie Bewick: Chief Business Officer
About the Company
Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products.
Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling the
drug-resistant bacteria that are at the centre of a global healthcare crisis.
